Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 17138823)

1.

Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction.

Viegas CS, Herfs M, Rafael MS, Enriquez JL, Teixeira A, Luís IM, van 't Hoofd CM, João A, Maria VL, Cavaco S, Ferreira A, Serra M, Theuwissen E, Vermeer C, Simes DC.

Biomed Res Int. 2014;2014:340216. doi: 10.1155/2014/340216. Epub 2014 May 18.

2.

Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.

Liabeuf S, Bourron O, Vemeer C, Theuwissen E, Magdeleyns E, Aubert CE, Brazier M, Mentaverri R, Hartemann A, Massy ZA.

Cardiovasc Diabetol. 2014 Apr 24;13:85. doi: 10.1186/1475-2840-13-85. Erratum in: Cardiovasc Diabetol. 2015;14:9. Olivier, Bourron [corrected to Bourron, Olivier].

3.

Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?

Saracyn M, Brodowska-Kania D, Niemczyk S.

ScientificWorldJournal. 2013 Nov 27;2013:170576. doi: 10.1155/2013/170576. Review.

4.

Vitamin K status in chronic kidney disease.

McCabe KM, Adams MA, Holden RM.

Nutrients. 2013 Nov 7;5(11):4390-8. doi: 10.3390/nu5114390. Review.

5.

VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.

Hammed A, Matagrin B, Spohn G, Prouillac C, Benoit E, Lattard V.

J Biol Chem. 2013 Oct 4;288(40):28733-42. doi: 10.1074/jbc.M113.457119. Epub 2013 Aug 8.

6.

Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis.

Shea MK, Booth SL, Miller ME, Burke GL, Chen H, Cushman M, Tracy RP, Kritchevsky SB.

Am J Clin Nutr. 2013 Jul;98(1):197-208. doi: 10.3945/ajcn.112.056101. Epub 2013 May 29.

7.

Phosphate: an old bone molecule but new cardiovascular risk factor.

Shobeiri N, Adams MA, Holden RM.

Br J Clin Pharmacol. 2014 Jan;77(1):39-54. doi: 10.1111/bcp.12117. Review.

8.

Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum.

Li Q, Guo H, Chou DW, Harrington DJ, Schurgers LJ, Terry SF, Uitto J.

Am J Pathol. 2013 Apr;182(4):1139-50. doi: 10.1016/j.ajpath.2012.12.037. Epub 2013 Feb 15.

9.

Mechanisms of arterial remodeling: lessons from genetic diseases.

van Varik BJ, Rennenberg RJ, Reutelingsperger CP, Kroon AA, de Leeuw PW, Schurgers LJ.

Front Genet. 2012 Dec 13;3:290. doi: 10.3389/fgene.2012.00290. eCollection 2012.

10.

Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Beazley KE, Eghtesad S, Nurminskaya MV.

J Biol Chem. 2013 Jan 25;288(4):2632-40. doi: 10.1074/jbc.M112.368639. Epub 2012 Dec 7.

11.

Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.

Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, Konoplyannikov M, Nurminskaya MV.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):43-51. doi: 10.1161/ATVBAHA.112.300260. Epub 2012 Nov 1.

12.

Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

Schurgers LJ, Joosen IA, Laufer EM, Chatrou ML, Herfs M, Winkens MH, Westenfeld R, Veulemans V, Krueger T, Shanahan CM, Jahnen-Dechent W, Biessen E, Narula J, Vermeer C, Hofstra L, Reutelingsperger CP.

PLoS One. 2012;7(8):e43229. doi: 10.1371/journal.pone.0043229. Epub 2012 Aug 29.

13.

Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

O'Seaghdha CM, Hwang SJ, Holden R, Booth SL, Fox CS.

Am J Nephrol. 2012;36(1):68-77. doi: 10.1159/000339005. Epub 2012 Jun 20.

14.

Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Shea MK, Holden RM.

Adv Nutr. 2012 Mar 1;3(2):158-65. doi: 10.3945/an.111.001644. Review.

15.

Elastin in large artery stiffness and hypertension.

Wagenseil JE, Mecham RP.

J Cardiovasc Transl Res. 2012 Jun;5(3):264-73. doi: 10.1007/s12265-012-9349-8. Review.

16.

The association of matrix Gla protein isomers with calcification in capsules surrounding silicone breast implants.

Hunter LW, Lieske JC, Tran NV, Miller VM.

Biomaterials. 2011 Nov;32(33):8364-73. doi: 10.1016/j.biomaterials.2011.07.073. Epub 2011 Aug 11.

17.

Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum.

Gorgels TG, Waarsing JH, Herfs M, Versteeg D, Schoensiegel F, Sato T, Schlingemann RO, Ivandic B, Vermeer C, Schurgers LJ, Bergen AA.

J Mol Med (Berl). 2011 Nov;89(11):1125-35. doi: 10.1007/s00109-011-0782-y. Epub 2011 Jul 2.

18.

Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.

Lomashvili KA, Wang X, Wallin R, O'Neill WC.

J Biol Chem. 2011 Aug 19;286(33):28715-22. doi: 10.1074/jbc.M111.251462. Epub 2011 Jun 24.

19.

Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults.

Shea MK, O'Donnell CJ, Vermeer C, Magdeleyns EJ, Crosier MD, Gundberg CM, Ordovas JM, Kritchevsky SB, Booth SL.

J Nutr. 2011 Aug;141(8):1529-34. doi: 10.3945/jn.111.139634. Epub 2011 May 31.

20.

Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum.

Brampton C, Yamaguchi Y, Vanakker O, Van Laer L, Chen LH, Thakore M, De Paepe A, Pomozi V, Szabó PT, Martin L, Váradi A, Le Saux O.

Cell Cycle. 2011 Jun 1;10(11):1810-20. Epub 2011 Jun 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk